table of content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biological Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Biological Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Therapeutic Protein
1.4.3 Monoclonal Antibody
1.4.4 Vaccine
1.5 Market by Application
1.5.1 Global Biological Drugs Market Share by Application: 2022-2027
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Biological Drugs Market
1.8.1 Global Biological Drugs Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Biological Drugs Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biological Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biological Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Biological Drugs Sales Volume Market Share by Region (2016-2021)
3.2 Global Biological Drugs Sales Revenue Market Share by Region (2016-2021)
3.3 North America Biological Drugs Sales Volume
3.3.1 North America Biological Drugs Sales Volume Growth Rate (2016-2021)
3.3.2 North America Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Biological Drugs Sales Volume
3.4.1 East Asia Biological Drugs Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Biological Drugs Sales Volume (2016-2021)
3.5.1 Europe Biological Drugs Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Biological Drugs Sales Volume (2016-2021)
3.6.1 South Asia Biological Drugs Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Biological Drugs Sales Volume (2016-2021)
3.7.1 Southeast Asia Biological Drugs Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Biological Drugs Sales Volume (2016-2021)
3.8.1 Middle East Biological Drugs Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Biological Drugs Sales Volume (2016-2021)
3.9.1 Africa Biological Drugs Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Biological Drugs Sales Volume (2016-2021)
3.10.1 Oceania Biological Drugs Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Biological Drugs Sales Volume (2016-2021)
3.11.1 South America Biological Drugs Sales Volume Growth Rate (2016-2021)
3.11.2 South America Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Biological Drugs Sales Volume (2016-2021)
3.12.1 Rest of the World Biological Drugs Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Biological Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Biological Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Biological Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Biological Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Biological Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Biological Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Biological Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Biological Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Biological Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Biological Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Biological Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Biological Drugs Sales Volume Market Share by Type (2016-2021)
14.2 Global Biological Drugs Sales Revenue Market Share by Type (2016-2021)
14.3 Global Biological Drugs Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Biological Drugs Consumption Volume by Application (2016-2021)
15.2 Global Biological Drugs Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Biological Drugs Business
16.1 Bristol-Myers Squibb
16.1.1 Bristol-Myers Squibb Company Profile
16.1.2 Bristol-Myers Squibb Biological Drugs Product Specification
16.1.3 Bristol-Myers Squibb Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Eli Lilly
16.2.1 Eli Lilly Company Profile
16.2.2 Eli Lilly Biological Drugs Product Specification
16.2.3 Eli Lilly Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Takeda
16.3.1 Takeda Company Profile
16.3.2 Takeda Biological Drugs Product Specification
16.3.3 Takeda Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Pfizer
16.4.1 Pfizer Company Profile
16.4.2 Pfizer Biological Drugs Product Specification
16.4.3 Pfizer Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Amgen
16.5.1 Amgen Company Profile
16.5.2 Amgen Biological Drugs Product Specification
16.5.3 Amgen Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 F. Hoffmann-La Roche
16.6.1 F. Hoffmann-La Roche Company Profile
16.6.2 F. Hoffmann-La Roche Biological Drugs Product Specification
16.6.3 F. Hoffmann-La Roche Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Johnson & Johnson
16.7.1 Johnson & Johnson Company Profile
16.7.2 Johnson & Johnson Biological Drugs Product Specification
16.7.3 Johnson & Johnson Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Merck
16.8.1 Merck Company Profile
16.8.2 Merck Biological Drugs Product Specification
16.8.3 Merck Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Abbott Laboratories
16.9.1 Abbott Laboratories Company Profile
16.9.2 Abbott Laboratories Biological Drugs Product Specification
16.9.3 Abbott Laboratories Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Baxter
16.10.1 Baxter Company Profile
16.10.2 Baxter Biological Drugs Product Specification
16.10.3 Baxter Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Novartis
16.11.1 Novartis Company Profile
16.11.2 Novartis Biological Drugs Product Specification
16.11.3 Novartis Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Biogen
16.12.1 Biogen Company Profile
16.12.2 Biogen Biological Drugs Product Specification
16.12.3 Biogen Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 GlaxoSmithKline
16.13.1 GlaxoSmithKline Company Profile
16.13.2 GlaxoSmithKline Biological Drugs Product Specification
16.13.3 GlaxoSmithKline Biological Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Biological Drugs Manufacturing Cost Analysis
17.1 Biological Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Biological Drugs
17.4 Biological Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Biological Drugs Distributors List
18.3 Biological Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Biological Drugs (2022-2027)
20.2 Global Forecasted Revenue of Biological Drugs (2022-2027)
20.3 Global Forecasted Price of Biological Drugs (2016-2027)
20.4 Global Forecasted Production of Biological Drugs by Region (2022-2027)
20.4.1 North America Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.3 Europe Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.7 Africa Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.9 South America Biological Drugs Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Biological Drugs Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Biological Drugs by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Biological Drugs by Country
21.2 East Asia Market Forecasted Consumption of Biological Drugs by Country
21.3 Europe Market Forecasted Consumption of Biological Drugs by Countriy
21.4 South Asia Forecasted Consumption of Biological Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Biological Drugs by Country
21.6 Middle East Forecasted Consumption of Biological Drugs by Country
21.7 Africa Forecasted Consumption of Biological Drugs by Country
21.8 Oceania Forecasted Consumption of Biological Drugs by Country
21.9 South America Forecasted Consumption of Biological Drugs by Country
21.10 Rest of the world Forecasted Consumption of Biological Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
